Home
- Eating Well (or at Least Not terribly) at Fast Food Resturants
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Insulin Cartridge Articles
Popular Insulin Cartridge Articles
Highly Recommended Insulin Cartridge Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Animas Receives Warning Letter From the FDA
OneTouch Ping
Animas Corporation, a division of Johnson & Johnson that manufactures insulin pumps, has been reprimanded by the FDA for not reporting serious problems resulting from use of its equipment. The parent company was warned that it could face fines and more for selling faulty insulin pumps and failing to disclose serious injuries to diabetic patients who used the OneTouch Ping and 2020 insulin pumps. According to reports, J&J continued to sell the pumps even after the company knew that some had failed.
Furthermore, the company did not submit a plan of correction to promptly report cases in which the devices might have caused or contributed to death or serious injury. Some patients who used the faulty pumps were hospitalized with dangerously high blood sugar, respiratory failure, and coma, as well as a diabetic ketoacidosis, a potentially fatal condition.
In some of the Animas pumps, the keypads that control how much insulin is automatically injected deteriorated prematurely. According to an Animas spokesperson, the company did not report three such incidents to the FDA within 30 days because in each case, the patient involved did not use the pump according to directions. In one case, the patient ignored an alarm signaling that the cap had come off the insulin cartridge inside the device, preventing insulin from being pumped into the body.
However, while Animas was working to line up a new keypad supplier, it continued to sell the old pumps. The FDA says that companies must continuously evaluate a product's safety over its lifespan and report irregularities.
Categories: 2020 Insulin Pumps, Animas Corporation, Diabetes, Diabetes, Diabetic Ketoacidosis, Faulty Insulin Pumps, FDA, Insulin Cartridge, Insulin Pumps, Johnson and Johnson, OneTouch Ping
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
this is funny....
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...